resurgence – tuberculosis – routine immunization – UK
ProMED-mail Archive Number 20100717.2386
Published Date 17-JUL-2010
Subject PRO/EDR> Tuberculosis, children – UK: use of BCG vaccine
Date: Thu 15 Jul 2010
Source: The Independent [edited]
http://www.independent.co.uk/life-style/health-and-families/health-news/ex=perts-urge-tb-vaccine-for-all-london-children-2026878.html
英国ロンドンで生まれたすべての赤ちゃんは、結核に対するワクチン接種を受けるべきである(公衆衛生専門医)。英国での小児結核の全患児のほぼ 45%は首都[ロンドン]であり、罹患率は上昇し、定期予防接種を導入する閾値を越えた (Health Protection Agency HPA 健康保護局の専門家)。
… People need to be aware of the main symptoms of TB, which include a fever and night sweats; a persistent cough; weight loss; and blood in your sputum (phlegm or spit). If you experience 2 or 3 of these symptoms for more than 3 weeks, you should go to your GP.”
結核の主症状は、発熱および盗汗(寝汗); 持続する咳; 体重減少; 血性痰。
3週間以上、これら症状の 2, 3つがあれば、GP [一般医, 総合診療医]にて受診すべきである。
A brief history of TB (tuberculosis)
1850s One person in 4 killed by TB in Europe and America
1882 Robert Koch discovers that TB is caused by an organism, Mycobacterium tuberculosis
1920 The 1st human trials of the vaccine Bacille Calmette Guerin (BCG)
1944 Streptomycin discovered and the 1st patient successfully treated
1952 Isoniazid discovered to treat TB patients
1953 BCG vaccination is introduced in secondary schools in the UK
1987 TB figures in England and Wales at their lowest since records began: 5086 cases
1987-2009 TB cases rise to reach 9153 in the UK
2004 National Action Plan, “Stopping Tuberculosis in England,” published by Chief Medical Officer
2005 Withdrawal of the BCG school vaccination programme in the UK.
New strategy targeted at immigrant families
[see
http://www.tbalert.org/tuberculosis/documents/BCGgovtrelease.pdf
]
[MOD. ML氏引用:
MMWR November 4, 2005 / 54(RR12);1-81
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5412a1.htm
Recommendations and Reports
Controlling Tuberculosis in the United States
Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America
...Vaccination with BCG is not recommended as a means to control TB in the United States because of the unproved efficacy of the vaccine in the U.S. population (174,175), its effect of confounding the results of tuberculin skin testing (176) and the success of other measures in reducing incidence of TB (16). ...
]
